Stockreport

IBRX INVESTOR REMINDER: ImmunityBio, Inc. Investors Have Until May 26, 2026 To Seek Lead Plaintiff Role

ImmunityBio, Inc.  (IBRX) 
PDF NEW YORK--(BUSINESS WIRE)--If you have suffered a loss on your ImmunityBio, Inc. (“ImmunityBio” or the “Company”) (NASDAQ:IBRX) investment, contact Lauren Molinaro o [Read more]